New scan could reveal hidden heart damage from cancer radiation

NCT ID NCT06373497

Recruiting now Knowledge-focused Sponsor: Katelyn Atkins Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This pilot study will test whether a special PET/MRI scan can detect real-time artery inflammation in the heart after chest radiation therapy. Ten adults with stage II-III or limited stage IV cancer who are at high risk for heart problems will be scanned before and 6 months after radiation. The goal is to see if this imaging method is feasible for spotting early signs of heart damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to monitor and predict heart damage from chest radiation in cancer patients.
What could go wrong: This is a very small, early-phase study with only 10 participants, so results may not apply to everyone. It is designed to test feasibility, not to prove a treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OLIGO-METASTATIC STAGE IV MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OLIGOMETASTATIC DISEASE

Contacts and locations

Locations

Cedars Sinai Medical Center
RECRUITING

Los Angeles, California, 90048, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.